☰

Ok Seon Kwon, Ph.D - Publications

Affiliations: 
Korea Research Institute of Bioscience and Biotechnology, Korea 
Tree Info Grants Similar researchers PubMed Report error

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Kwon OS, Lee H, Kong HJ, Kwon EJ, Park JE, Lee W, Kang S, Kim M, Kim W, Cha HJ. Correction to: Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer. Oncogene. PMID 33574481 DOI: 10.1038/s41388-021-01642-7  0.6
2020 Kong HJ, Kwon EJ, Kwon OS, Lee H, Choi JY, Kim YJ, Kim W, Cha HJ. Crosstalk between YAP and TGFβ regulates SERPINE1 expression in mesenchymal lung cancer cells. International Journal of Oncology. PMID 33367928 DOI: 10.3892/ijo.2020.5153  0.678
2020 Choi JY, Lee H, Kwon EJ, Kong HJ, Kwon OS, Cha HJ. TGFβ promotes YAP-dependent AXL induction in mesenchymal-type lung cancer cells. Molecular Oncology. PMID 33207077 DOI: 10.1002/1878-0261.12857  0.682
2020 Kwon OS, Kwon EJ, Kong HJ, Choi JY, Kim YJ, Lee EW, Kim W, Lee H, Cha HJ. Systematic identification of a nuclear receptor-enriched predictive signature for erastin-induced ferroptosis. Redox Biology. 37: 101719. PMID 32979793 DOI: 10.1016/j.redox.2020.101719  0.657
2020 Kim KT, Park JC, Jang HK, Lee H, Park S, Kim J, Kwon OS, Go YH, Jin Y, Kim W, Lee J, Bae S, Cha HJ. Safe scarless cassette-free selection of genome-edited human pluripotent stem cells using temporary drug resistance. Biomaterials. 262: 120295. PMID 32916603 DOI: 10.1016/j.biomaterials.2020.120295  0.629
2020 Kwon OS, Lee H, Kong HJ, Kwon EJ, Park JE, Lee W, Kang S, Kim M, Kim W, Cha HJ. Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer. Oncogene. PMID 32388539 DOI: 10.1038/s41388-020-1316-2  0.654
2020 Kwon OS, Lee H, Kim YJ, Cha HJ, Song NY, Lee MO. ERK Dephosphorylation through MKP1 Deacetylation by SIRT1 Attenuates RAS-Driven Tumorigenesis. Cancers. 12. PMID 32276460 DOI: 10.3390/cancers12040909  0.557
2019 Kwon T, Kwon OS, Cha HJ, Sung BJ. Stochastic and Heterogeneous Cancer Cell Migration: Experiment and Theory. Scientific Reports. 9: 16297. PMID 31704971 DOI: 10.1038/s41598-019-52480-3  0.624
2019 Kim DH, Jang JH, Kwon OS, Cha HJ, Chun KS, Surh YJ. Nrf2-induced reductive stress favours self-renewal of breast cancer stem-like cells via the FoxO3a-Bmi-1 axis. Antioxidants & Redox Signaling. PMID 31672029 DOI: 10.1089/ars.2019.7730  0.648
2019 Kwon OS, Kim W, Cha HJ, Lee H. In silico drug repositioning: from large-scale transcriptome data to therapeutics. Archives of Pharmacal Research. PMID 31482491 DOI: 10.1007/s12272-019-01176-3  0.537
2019 Go YH, Lim C, Jeong HC, Kwon OS, Chung S, Lee H, Kim W, Suh YG, Son WS, Lee MO, Cha HJ, Kim SH. Structure-Activity Relationship Analysis of YM155 for Inducing Selective Cell Death of Human Pluripotent Stem Cells. Frontiers in Chemistry. 7: 298. PMID 31157201 DOI: 10.3389/fchem.2019.00298  0.618
2018 Go YH, Lee HJ, Kong HJ, Jeong HC, Lee DY, Hong SK, Sung SH, Kwon OS, Cha HJ. Screening of cytotoxic or cytostatic flavonoids with quantitative Fluorescent Ubiquitination-based Cell Cycle Indicator-based cell cycle assay. Royal Society Open Science. 5: 181303. PMID 30662739 DOI: 10.1098/rsos.181303  0.597
2018 Hong SK, Lee H, Kwon OS, Song NY, Lee HJ, Kang S, Kim JH, Kim M, Kim W, Cha HJ. Large-scale pharmacogenomics based drug discovery for ITGB3 dependent chemoresistance in mesenchymal lung cancer. Molecular Cancer. 17: 175. PMID 30563517 DOI: 10.1186/s12943-018-0924-8  0.612
2018 Cho SJ, Kim KT, Jeong HC, Park JC, Kwon OS, Song YH, Shin JG, Kang S, Kim W, Shin HD, Lee MO, Moon SH, Cha HJ. Selective Elimination of Culture-Adapted Human Embryonic Stem Cells with BH3 Mimetics. Stem Cell Reports. PMID 30293852 DOI: 10.1016/j.stemcr.2018.09.002  0.627
2018 Cho SJ, Kim KT, Kim JS, Kwon OS, Go YH, Kang NY, Heo H, Kim MR, Han DW, Moon SH, Chang YT, Cha HJ. A fluorescent chemical probe CDy9 selectively stains and enables the isolation of live naïve mouse embryonic stem cells. Biomaterials. 180: 12-23. PMID 30014963 DOI: 10.1016/J.Biomaterials.2018.07.007  0.605
2018 Cui YH, Kim H, Lee M, Yi JM, Kim RK, Uddin N, Yoo KC, Kang JH, Choi MY, Cha HJ, Kwon OS, Bae IH, Kim MJ, Kaushik N, Lee SJ. FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation. Oncogene. PMID 29973690 DOI: 10.1038/s41388-018-0372-3  0.602
2017 Kwon OS, Kwon SJ, Kim JS, Lee G, Maeng HJ, Lee J, Hwang GS, Cha HJ, Chun KH. Designing Tyrosinase siRNAs by Multiple Prediction Algorithms and Evaluation of Their Anti-Melanogenic Effects. Biomolecules & Therapeutics. PMID 29223142 DOI: 10.4062/biomolther.2017.115  0.547
2017 Kwon SJ, Kwon OS, Kim KT, Go YH, Yu SI, Lee BH, Miyoshi H, Oh E, Cho SJ, Cha HJ. Role of MEK partner-1 in cancer stemness through MEK/ERK pathway in cancerous neural stem cells, expressing EGFRviii. Molecular Cancer. 16: 140. PMID 28830458 DOI: 10.1186/S12943-017-0703-Y  0.667
2017 Kwon OS, Han MJ, Cha HJ. Suppression of SIRT2 and altered acetylation status of human pluripotent stem cells: possible link to metabolic switch during reprogramming. Bmb Reports. PMID 28683850  0.599
2017 Kwon OS, Hong SK, Kwon SJ, Go YH, Oh E, Cha HJ. BCL2 induced by LAMTOR3/MAPK is a druggable target of chemoradioresistance in mesenchymal lung cancer. Cancer Letters. PMID 28606806 DOI: 10.1016/j.canlet.2017.05.019  0.665
2017 Kim I, Kim KS, Kwon OS, Cha HJ, Park KS. Ell3 stimulates 5-FU resistance in a breast cancer cell line. Oncology Letters. 13: 4173-4179. PMID 28588704 DOI: 10.3892/ol.2017.5996  0.662
2017 Jeong HC, Park SJ, Choi JJ, Go YH, Hong SK, Kwon OS, Shin JG, Kim RK, Lee MO, Lee SJ, Shin HD, Moon SH, Cha HJ. PRMT8 Controls the Pluripotency and Mesodermal Fate of Human Embryonic Stem Cells by Enhancing the PI3K/AKT/SOX2 axis. Stem Cells (Dayton, Ohio). PMID 28543863 DOI: 10.1002/stem.2642  0.621
2017 Cho SJ, Cha BS, Kwon OS, Lim J, Shin DM, Han DW, Ishitani T, Jho EH, Fornace AJ, Cha HJ. Wip1 directly dephosphorylates NLK and increases Wnt activity during germ cell development. Biochimica Et Biophysica Acta. PMID 28185954 DOI: 10.1016/J.Bbadis.2017.01.028  0.688
2016 Kwon OS, Kim KT, Lee E, Kim M, Choi SH, Li H, Fornace AJ, Cho JH, Lee YS, Lee JS, Lee YJ, Cha HJ. Induction of MiR-21 by Stereotactic Body Radiotherapy Contributes to the Pulmonary Fibrotic Response. Plos One. 11: e0154942. PMID 27171163 DOI: 10.1371/Journal.Pone.0154942  0.634
2016 Hong SK, Park JR, Kwon OS, Kim KT, Bae GY, Cha HJ. Induction of integrin β3 by sustained ERK activity promotes the invasiveness of TGFβ-induced mesenchymal tumor cells. Cancer Letters. PMID 27085460 DOI: 10.1016/j.canlet.2016.04.012  0.647
2015 Kwon OS, Oh E, Park JR, Lee JS, Bae GY, Koo JH, Kim H, Choi YL, Choi YS, Kim J, Cha HJ. GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma. Oncotarget. PMID 26544896 DOI: 10.18632/oncotarget.6019  0.614
2015 Lee JS, Park JR, Kwon OS, Lee TH, Nakano I, Miyoshi H, Chun KH, Park MJ, Lee HJ, Kim SU, Cha HJ. SIRT1 is required for oncogenic transformation of neural stem cells and for the survival of "cancer cells with neural stemness" in a p53-dependent manner. Neuro-Oncology. 17: 95-106. PMID 25096191 DOI: 10.1093/neuonc/nou145  0.653
2014 Lee JS, Park JR, Kwon OS, Kim H, Fornace AJ, Cha HJ. Off-target response of a Wip1 chemical inhibitor in skin keratinocytes. Journal of Dermatological Science. 73: 125-34. PMID 24126074 DOI: 10.1016/J.Jdermsci.2013.09.003  0.654
Show low-probability matches.